Pharmaceutical.Report

Iambic Therapeutics, a biotech company developing novel therapeutics from its unique generative AI discovery platform, has announced the closing of an oversubscribed $100 million Series B financing co-led by Ascenta Capital and Abingworth, and including new investors NVIDIA, Illumina Ventures, gradiant corporation, and independent board member Bill Rastetter.

Click the link below to read the full news:
https://bit.ly/3F9FLtR

Iambic Therapeutics Announces Close of Oversubscribed $100 Million Iambic Therapeutics a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, today announced the closing

MEDIA 7's The Pharmaceutical.Report invites you to be a part of the 3rd Saudi International Pharma Expo 2023, set to take place in Riyadh, Saudi Arabia, Riyadh International Convention and Exhibition Center (RICEC) from October 9th to 11th, 2023.

Join this leading event and explore the entire laboratory industry value chain, from raw materials to finished formulations, distributors, and healthcare networks. Engage with industry innovations and connect with leaders, researchers, and peers.

More details are available at: https://bit.ly/3F7152V

Date: October 09-11, 2023
In-Person
Reema Sakkijha | 1st Arabia Tradeshows & Conferences

Register now: https://bit.ly/3F7152V

3rd Saudi International Pharma Expo Pharma is committed to providing a complete solution to the Laboratory industry.